Search Results 2651-2660 of 16780 for Interphase
The atezolizumab plus obinutuzumab) (Arm E) will enroll participants with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Mayo Clinic is pioneering and refining regenerative procedures that are a bridge to transplant. These procedures are providing new options for strengthening ...
A recent Mayo Clinic retrospective study shows that cancer practices can integrate telehealth without duplicative care, allowing for a more streamlined ...
This is a prospective, non-interventional, multicenter, registry of patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!